| Literature DB >> 15294323 |
Anne Jarry1, Damien Masson, Elisabeth Cassagnau, Sigrid Parois, Christian Laboisse, Marc G Denis.
Abstract
BRAF is a cytoplasmic serine/threonine kinase in the MAPK pathway that transduces signals from RAS family members to MEK1/2. Mutations in the BRAF gene have been described in the majority of cutaneous melanomas, papillary thyroid carcinoma and to a lesser extent in other cancers. The predominant mutation reported is a single transversion in exon 15 (T1799A). We designed a real-time allele-specific PCR to detect this mutation. This assay allowed us to detect this alteration in samples containing 2% of cells harboring this mutation, which is equivalent to 1% mutated DNA, assuming heterozygosity for the allele. Using this assay, we then tested 44 human primary colorectal tumors. We found the V600E mutation in four samples (9.1%). Analysis of DNA extracted from paraffin-embedded sections gave similar results, indicating that archived tissues can also be analyzed using this assay. The advantages of this method include: (1) rapidity; (2) sensitivity; (3) ease; (4) large throughput; (5) low cost and (6) the small quantities of DNA needed.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15294323 DOI: 10.1016/j.mcp.2004.05.004
Source DB: PubMed Journal: Mol Cell Probes ISSN: 0890-8508 Impact factor: 2.365